UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current
Report Pursuant
to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) August 15, 2003
Boston Biomedica, Inc.
(Exact Name Of Registrant As Specified In Its Charter)
|
Massachusetts |
||
|
(State or Other Jurisdiction of Incorporation) |
||
|
|
|
|
|
0-21615 |
|
04-2652826 |
|
(Commission File Number) |
|
(I.R.S. Employer Identification No.) |
|
|
|
|
|
375 West Street, West Bridgewater, MA |
|
02379-1040 |
|
(Address of Principal Executive Offices) |
|
(Zip Code) |
|
|
|
|
|
(508) 580-1900 |
||
|
(Registrant’s Telephone Number, Including Area Code) |
||
|
|
|
|
|
N/A |
||
|
(Former Name or Former Address, if Changed Since Last Report) |
||
Item 7. Financial Statements and Exhibits.
(c) Exhibits.
|
Exhibit |
|
Description |
|
|
|
99.1 |
|
Press release dated August 15, 2003 of Boston Biomedica, Inc. (the “Company”) announcing its financial results for the second quarter ended June 30, 2003. |
Item 12. Results of Operations and Financial Condition
On August 15, 2003, the Company issued a press release announcing its financial results for the second quarter ended June 30, 2003. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein in its entirety by reference.
Limitation on Incorporation by Reference. The information furnished in this Item 12 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such a filing.
Cautionary Note Regarding Forward-Looking Statements. Except for historical information contained in the press release attached as an exhibit hereto, the press release contains forward-looking statements which involve certain risks and uncertainties that could cause actual results to differ materially from those expressed or implied by these statements. Please refer to the cautionary note in the press release regarding these forward-looking statements.
2
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.
|
Dated: August 19, 2003 |
BOSTON BIOMEDICA, INC. |
||
|
|
|
||
|
|
|
||
|
|
By: |
/s/ Kevin W. Quinlan |
|
|
|
|
Kevin W.
Quinlan, President, Chief Operating |
|
3
EXHIBIT INDEX
|
Exhibit |
|
Description |
|
|
|
99.1 |
|
Press release dated August 15, 2003 of Boston Biomedica, Inc. announcing its financial results for the second quarter ended June 30, 2003. |
4